Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Eugia Pharma Specialities Limited
FDA Inspection
•Eugia Pharma Specialities Limited•February 20, 2018

Eugia Pharma Specialities Limited – FDA Inspection, Feb 20, 2018

Record Details

This FDA Inspection record concerns Eugia Pharma Specialities Limited, with an inspection on February 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Eugia Pharma Specialities Limited
Inspection Date
February 20, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Yasamin Ameri (FDA Associated Person)
View Company Profile

ID · a27b351f-f62f-41cb-b50f-40902d82d76e

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1041554
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

9
  1. 21 CFR 211.160(a)Following/documenting laboratory controls
  2. 21 CFR 211.165(d)Acceptance/Rejection Levels
  3. 21 CFR 211.25(a)Training , Education , Experience overall
  4. 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
  5. 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
  6. 21 CFR 211.63Equipment Design, Size and Location
  7. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  8. 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
  9. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Eugia Pharma Specialities Limited

7
DateClassificationOfficeProject area
February 6, 2026Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
February 2, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 14, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 28, 2017Not classifiedOffice of Inspections and InvestigationsGeneric Drug Evaluation
September 16, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Eugia Pharma Specialities Limited
  • FDA Inspection 1301166 - 2026-02-06
  • FDA Inspection 1228546 - 2024-02-02
  • FDA Inspection 1074573 - 2018-12-14
  • FDA Inspection 1010785 - 2017-04-28
  • FDA Inspection 989530 - 2016-09-16

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eugia Pharma Specialities Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.